Long-term VEDOKIDS results: implications for practice and research
- PMID: 39788135
- DOI: 10.1016/S2468-1253(24)00381-9
Long-term VEDOKIDS results: implications for practice and research
Conflict of interest statement
I am a patient living with ulcerative colitis and currently taking vedolizumab; I acknowledge that my personal experiences could influence my perspective on the treatment. During the preparation of this work the author used ChatGPT in order to shorten the manuscript to word limits. After using this tool, the author reviewed and edited the content as needed and takes full responsibility for the content of the publication.
Comment on
-
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study.Lancet Gastroenterol Hepatol. 2025 Mar;10(3):234-247. doi: 10.1016/S2468-1253(24)00319-4. Epub 2025 Jan 6. Lancet Gastroenterol Hepatol. 2025. PMID: 39788134
Publication types
LinkOut - more resources
Full Text Sources